LeMaitre Vascular, Inc. reports results for the quarter ended September 30 - Earnings Summary

What happened

LeMaitre Vascular reported adjusted earnings of 65 cents per share for the quarter ended September 30, up from 62 cents a year earlier but below analysts’ 69-cent average expectation. Revenue increased 11.3% to $67.97 million, exceeding analysts’ $67.39 million estimate, and net income was $15.02 million.

Confirmed

Global impact / market context

The results show revenue growing faster than the prior-year comparison while earnings per share missed the average forecast. If that earnings gap reflects costs rising faster than sales, it could limit profit growth; the article does not identify the cause, so investors should not assume a specific pressure.

Analyst inference

Analyst expectations had edged down about 0.1% over three months, with no estimate revisions in the latest 30 days. The average rating was “buy,” but that is an analyst opinion, not a guarantee; shares had fallen 2.4% this quarter, according to the article.

Confirmed

What to watch

1. Compare upcoming revenue growth with earnings per share to see whether the reported sales increase is translating into higher earnings, rather than being offset by costs. Analyst inference
2. Check the next results for management’s explanation of the earnings-per-share shortfall against the 69-cent analyst average; the supplied article does not give its cause. Analyst inference
3. Track analyst estimate changes and the reported share-price trend: estimates were unchanged in the past 30 days, while shares were down 2.4% this quarter. Confirmed

Evidence

• Original source link unavailable